CERVARIX
Vaccin Papillomavirus Humain [Types 16, 18] (Recombinant, avec adjuvant, adsorbé)
Public price
384,00 MAD
Active substance
Vaccin Papillomavirus Humain [Types 16, 18] (Recombinant, avec adjuvant, adsorbé)
Laboratory
GSK MAROC
What is this medicine?
CERVARIX contains Vaccin Papillomavirus Humain [Types 16, 18] (Recombinant, avec adjuvant, adsorbé). Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
Vaccin Papillomavirus Humain [Types 16, 18] (Recombinant, avec adjuvant, adsorbé), Vaccin suspension injectable [V], 0.5 ML, 1 flacon de 0.5 ML
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Vaccins
Laboratory
GSK MAROC
Strength
0.5 ML
Form
Vaccin suspension injectable [V]
Presentation
1 flacon de 0.5 ML
Therapeutic class
Vaccins
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 384,00 MAD